WASHINGTON: A team of scientists said on Wednesday they had developed a male oral contraceptive that was 99% effective in mice and did not cause observable side effects, with the drug expected to enter human trials by the end of this year.
The findings will be presented at the American Chemical Society's spring meeting, and mark a key step towards expanding birth control options -- as well as responsibilities -- for men.
